Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
CTRI |
Last refreshed on:
|
24 November 2021 |
Main ID: |
CTRI/2015/01/005480 |
Date of registration:
|
30-01-2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
To re assess the association of sympathetic activity and hypertension and to see that this sympathetic activity increases LV contractility which is responsible for high BP
|
Scientific title:
|
Assessment of left ventricular ejection force and sympathetic skin response in normotensive and hypertensive subjects |
Date of first enrolment:
|
07-01-2015 |
Target sample size:
|
100 |
Recruitment status: |
Open to Recruitment |
URL:
|
http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=10645 |
Study type:
|
Observational |
Study design:
|
Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Case Record Numbers Blinding and masking:Participant and Outcome Assessor Blinded
|
Phase:
|
N/A
|
|
Countries of recruitment
|
India
| | | | | | | |
Contacts
|
Name:
|
Tarun Saxena
|
Address:
|
E/196
Shastri Nagar Ajmer
305001
Ajmer, RAJASTHAN
India |
Telephone:
|
09829089284 |
Email:
|
yogdiab@gmail.com |
Affiliation:
|
Mittal Hospital and Research Center |
|
Name:
|
Tarun Saxena
|
Address:
|
E/196
Shastri Nagar Ajmer
305001
Ajmer, RAJASTHAN
India |
Telephone:
|
09829089284 |
Email:
|
yogdiab@gmail.com |
Affiliation:
|
Mittal Hospital and Research Center |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: The participants will be hypertensive stage 1 and 2 subjects and normotensive subjects of similar age and sex.
Exclusion criteria: Ischemic heart disease, thyrotoxicosis, anemia, dyslipidemia, secondary hypertension.
Age minimum:
Age maximum:
Gender:
|
Health Condition(s) or Problem(s) studied
|
Health Condition 1: null- Essential Hypertension
|
Intervention(s)
|
Control Intervention1: Echocardiography, sympathetic skin response.: Echocardiographic assessment of left ventricular ejection force with the help of aortic acceleration time, maximum aortic velocity and sympathetic skin response with the help of EMG electrodes.
|
Primary Outcome(s)
|
Aortic acceleration time, maximum aortic velocity, left ventricular ejection force, sympathetic skin responseTimepoint: Assessment will be done only once i.e.at the time of first examination(0 month)
|
Secondary Outcome(s)
|
Left ventricular stroke volume, left ventricular hypertrophyTimepoint: Stroke volume by VTI and assessment of volume (EDV and ESV) in four chamber trans thoracic view.
|
Source(s) of Monetary Support
|
Mittal Hospital
|
Ethics review
|
Status: Approved
Approval date: 25/12/2014
Contact:
Mittal Hospital Ethical committee
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|